Literature DB >> 15489565

The epidemiology of fatty liver.

Stefano Bellentani1, Giorgio Bedogni, Lucia Miglioli, Claudio Tiribelli.   

Abstract

There are insufficient data available on the epidemiology of fatty liver to design a complete and correct view of the prevalence, incidence and natural history of this disorder. This article, mainly based on the revision of recently published papers in this field, attempts to give an overview of the current findings on the epidemiology of fatty liver worldwide. The possible factors involved in the development of fat accumulation in the liver, and their potential role in the progression of the disorder will be also addressed.

Mesh:

Year:  2004        PMID: 15489565     DOI: 10.1097/00042737-200411000-00002

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  38 in total

1.  The prevalence and adverse profiles of fatty liver disease among different ethnic public servants in Urumqi of Xinjiang Uygur Autonomous Region in China.

Authors:  Dan Chen; Jie Guan; Xiang Xie; Wei-Yun Zhao; Palida Abulaiti; Yu Wang; Zhi-Qin Cheng; Jing Zhang; Ying Gao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Molecular pathogenesis of nonalcoholic steatohepatitis: today and tomorrow.

Authors:  Anna Alisi; Valerio Nobili
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

3.  Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.

Authors:  Iradj Maleki; Mahmood Reza Aminafshari; Tarang Taghvaei; Vahid Hosseini; Alireza Rafiei; Zhila Torabizadeh; Maryam Barzin; Elahe Orang
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania.

Authors:  Aderonke A Akinkugbe; Gary D Slade; A Sidney Barritt; Stephen R Cole; Steven Offenbacher; Astrid Petersmann; Thomas Kocher; Markus M Lerch; Julia Mayerle; Henry Völzke; Gerardo Heiss; Birte Holtfreter
Journal:  J Clin Periodontol       Date:  2017-09-22       Impact factor: 8.728

Review 5.  Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.

Authors:  Andrea Tannapfel; Helmut Denk; Hans-Peter Dienes; Cord Langner; Peter Schirmacher; Michael Trauner; Berenike Flott-Rahmel
Journal:  Virchows Arch       Date:  2011-03-26       Impact factor: 4.064

6.  Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis.

Authors:  Paolo Sorrentino; Luigi Terracciano; Salvatore D'Angelo; Umberto Ferbo; Alessandra Bracigliano; Luciano Tarantino; Alessandro Perrella; Oreste Perrella; Giovanni De Chiara; Luigi Panico; Noè De Stefano; Mariolina Lepore; Raffaela Vecchione
Journal:  J Gastroenterol       Date:  2010-10       Impact factor: 7.527

Review 7.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

8.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 9.  The genetics of NAFLD.

Authors:  Quentin M Anstee; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 10.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.